| |
| |
|
| Insider
Information: |
Graham Ginger L |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
141,600 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$38,464 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
141,600 |
|
|
| Total
Value |
$38,464 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2009-03-18 |
139,450 |
2005-01-04 |
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director |
2011-04-01 |
0 |
2019-11-08 |
0 |
Premium* |
|
|
Walgreens Boots Alliance, Inc. |
WBA |
Director |
2017-10-26 |
2,150 |
2017-10-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
President and Chief Executive |
• – – |
2005-01-04 |
4 |
OE |
$7.13 |
$213,750 |
D/D |
30,000 |
105,600 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President and Chief Executive |
• – – |
2005-05-06 |
4 |
B |
$16.65 |
$199,800 |
D/D |
12,000 |
118,535 |
2.74 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-05 |
4 |
OE |
$12.25 |
$122,500 |
D/D |
10,000 |
129,706 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President and Chief Executive |
• – – |
2006-01-31 |
4 |
A |
$19.46 |
$23,322 |
D/D |
921 |
130,627 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President and Chief Executive |
• – – |
2006-06-09 |
4 |
OE |
$16.54 |
$249,981 |
D/D |
10,869 |
141,496 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Executive Officer |
• – – |
2006-12-05 |
4 |
OE |
$23.00 |
$49,979 |
D/D |
2,173 |
144,082 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Executive Officer |
• – – |
2007-01-31 |
4 |
A |
$36.07 |
$15,005 |
D/D |
416 |
144,498 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Executive Officer |
• – – |
2007-02-28 |
4 |
A |
$33.07 |
$4,200 |
D/D |
127 |
144,625 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
• – – |
2007-06-12 |
4 |
OE |
$23.00 |
$66,654 |
D/D |
2,898 |
147,523 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
• – – |
2007-08-06 |
4 |
OE |
$4.38 |
$43,750 |
D/D |
10,000 |
157,523 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
• – – |
2007-08-06 |
4 |
AS |
$49.50 |
$495,013 |
D/D |
(10,000) |
147,523 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
• – – |
2007-08-07 |
4 |
AS |
$50.51 |
$505,101 |
D/D |
(10,000) |
147,523 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
• – – |
2007-08-07 |
4 |
OE |
$10.25 |
$102,500 |
D/D |
10,000 |
157,523 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
• – – |
2007-08-08 |
4 |
OE |
$9.16 |
$337,250 |
D/D |
23,000 |
155,523 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
• – – |
2007-08-08 |
4 |
AS |
$51.11 |
$1,183,598 |
D/D |
(23,000) |
147,523 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
• – – |
2007-09-05 |
4 |
OE |
$16.54 |
$33,344 |
D/D |
1,450 |
148,973 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2008-02-04 |
4 |
S |
$31.98 |
$29,041 |
D/D |
(908) |
148,015 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2009-03-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,565 |
139,450 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2011-04-01 |
4 |
A |
$24.60 |
$9,988 |
I/I |
406 |
406 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2011-07-01 |
4 |
A |
$27.91 |
$9,992 |
I/I |
358 |
764 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2011-10-01 |
4 |
A |
$21.98 |
$9,979 |
I/I |
454 |
1,218 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2012-01-01 |
4 |
A |
$25.39 |
$9,978 |
I/I |
393 |
1,611 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2012-04-01 |
4 |
A |
$30.61 |
$9,979 |
I/I |
326 |
1,937 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2012-07-01 |
4 |
A |
$33.40 |
$9,987 |
I/I |
299 |
2,236 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2012-10-01 |
4 |
A |
$35.89 |
$10,336 |
I/I |
288 |
2,524 |
0 |
- |
|
58 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
